Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VasIntervent: Stenting for Refractory ICAS
NCT04393025Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Jun 2016
- Primary completion
- Jun 2018
01
Overview
Phase 4, open-label trial in Intracranial arterial stenosis (ICAS) and ischemic stroke (2 arms), sponsored by Ain Shams University. Primary endpoints: Clinical improvement of IC stented patients in comparison to medically treated at 3 months, Functional improvement of IC stented patients in comparison to medically treated at 3 months and 1 more. Started Jun 2016; status: completed.
02
Conditions
Intracranial arterial stenosis (ICAS)ischemic stroke
Beyond the preview
Go deeper on NCT04393025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04393025.